Joyce Laviscount News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bexion Pharmaceuticals, Inc to Present at BIO International Convention 2024

Bexion Pharmaceuticals, Inc to Present at BIO International Convention 2024
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesWilliam windhamJoyce laviscountPrnewswire bexion pharmaceuticals incBexion pharmaceuticalsBexion pharmaceuticals incInternational conventionSolebury strategic communicationsBiotechnology innovation organizationInnovation organizationChief executive

Bexion Pharmaceuticals, Inc Announces Poster Presentation on BXQ-350 at the American Association for Cancer Research (AACR) Annual Meeting 2024

/PRNewswire/ Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor.

United statesSan diegoGilles tapolskyJoyce laviscountWilliam windhamPrnewswire bexion pharmaceuticals incSolebury strategic communicationsBexion pharmaceuticals incOnline program plannerAmerican association for cancer researchBexion pharmaceuticalsPharmacology translational sciencesAmerican associationCancer researchAnnual meetingBoard number

Bexion Pharmaceuticals, Inc Appoints Dr Tariq Arshad as Chief Medical Officer

/PRNewswire/ Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a new generation of biologic therapy to treat solid tumor.

United statesScott shivelyWilliam windhamJoyce laviscountTariq arshadPrnewswire bexion pharmaceuticals incHead of clinical researchSociety for immunotherapy of cancerAmerican association of cancer researchBexion pharmaceuticals incSolebury strategic communicationsAmerican society of clinical oncologyBexion pharmaceuticalsChief medicalChief medical officerChief executive

Bexion Pharmaceuticals, Inc to Present at Biotech Showcase 2024

/PRNewswire/ Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a new generation of biologic therapy to treat solid tumor.

San franciscoUnited statesScott shivelyJoyce laviscountWilliam windhamSolebury strategic communicationsBexion pharmaceuticals incCompany investor contactPrnewswire bexion pharmaceuticals incUnion squareBexion pharmaceuticalsBiotech showcaseAnnual healthcare conferenceHilton san franciscoBallroom levelChief financial officer

Bexion Pharmaceuticals, Inc to Participate in the 3rd Annual Needham Private Biotech Company Virtual 1x1 Forum

/PRNewswire/ Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a new generation of biologic therapy to treat solid tumor.

William windhamScott shivelyJoyce laviscountBexion pharmaceuticalsBexion pharmaceuticals incPrnewswire bexion pharmaceuticals incNeedham private biotech company virtualSolebury strategic communicationsAnnual needham private biotech company virtualChief financial officer